🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cognitive Neurodegenerative

Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease NCT07803055NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: blood sampling Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline NCT05907343NA1 site📍 Austin University of Texas at Austin · Tests: Closed-loop TBS, Open-loop TBS Effect of CAFfeine on Cognition in Alzheimer's Disease NCT04570085Phase 317 sites📍 Amiens📍 Arras📍 Beauvais University Hospital, Lille · Tests: Caffeine, Placebo Neurocognitive Assessment Platform 4 Alzheimer NCT07272811n/a1 site📍 Milan IRCCS San Raffaele The Links Between Executive and Linguistic Processes and Their Lesional Determinants From a Verbal Fluency Task NCT05875103NA1 site📍 Amiens Centre Hospitalier Universitaire, Amiens · Tests: linguistic processes Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function NCT07289061NA1 site📍 Thessaloniki Aristotle University Of Thessaloniki · Tests: Positive Psychology Intervention, Treatment as usual (TAU) Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia NCT07284290Phase 41 site📍 Richmond Virginia Commonwealth University · Tests: Syn-One skin biopsy, Multi modal MRI, Assessment of dynamic EEG features over 48-hour periods across all study aims, Pl… Exercise to Improve Brain Health in Older African Americans NCT05597124Phase 21 site📍 Newark Rutgers, The State University of New Jersey · Tests: Cardio-Dance Fitness, Strength, Flexibility & Balance Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease NCT05924425Phase 41 site📍 Montpellier University Hospital, Montpellier · Tests: Daridorexant 50 mg, Placebo, Polysomnography, Neuropsychological assessment, Questionnaires on sleep and behavioural pr… Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo Clinical Cohort of Memory Disorders NCT07880275n/a1 site📍 Seoul Yonsei University Study to Understand Novel Biomarkers in Researching Dementia NCT06547099n/a1 site📍 St Louis Washington University School of Medicine · Tests: Clinical tau PET, Clinical amyloid test, Research blood collection, Cognitive assessments Levetiracetam for Persons at Risk for Alzheimer's Disease NCT07477431Phase 22 sites📍 Toronto📍 Toronto Sunnybrook Health Sciences Centre · Tests: Levetiracetam (LEV), Placebo Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease NCT07207122NA4 sites📍 Tucson📍 Santa Monica📍 Gainesville Sanmai Technologies PBC dba Sanmai · Tests: Gen0Bh Transcranial Focused Ultrasound System (Active), Gen0Bh Transcranial Focused Ultrasound System (Sham) Cardiac Amyloid Deposits and Heart Dysfunction in Alzheimer's Disease NCT07154394n/a1 site📍 Essen University Hospital, Essen Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments NCT07154511Phase 1, Phase 21 site📍 Ann Arbor Prabesh Kanel · Tests: Tributyrin, Placebo Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease NCT03810794NA3 sites📍 Shanghai📍 Shanghai📍 Shanghai Jian Pei,MD · Tests: Acupuncture, Donepezil Individualized Transcranial Magnetic Stimulation in Parkinsonian Disorders NCT07570212NA1 site📍 Beijing Peking University First Hospital · Tests: TMS Retinal Imaging in Neurodegenerative Disease NCT03233646n/a1 site📍 Durham Duke University · Tests: Retinal and Choroidal Imaging ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults NCT07392723Phase 21 site📍 New Brunswick Michal Schnaider Beeri, Ph.D. · Tests: Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group Repurposing Siponimod for Alzheimer's Disease NCT06639282Phase 21 site📍 Phoenix St. Joseph's Hospital and Medical Center, Phoenix · Tests: Siponimod, Placebo Financial Abilities in Neurological Diseases. Development of a Telerehabilitation Program: FINAGE NCT05826548NA1 site📍 Lido IRCCS San Camillo, Venezia, Italy · Tests: Telerehabilitation group, Conventioanl treatment group Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease NCT05887674NA1 site📍 Shanghai Ruijin Hospital · Tests: Diet intervention, Exercise, Cognitive training A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE) NCT07633470Phase 422 sites📍 Irvine📍 Orange📍 Aventura Alpha Cognition, Inc · Tests: Zunveyl® Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease NCT05968703NA1 site📍 Stanford Helen M. Bronte-Stewart · Tests: Combined STN+NBM DBS The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study NCT05988385NA4 sites📍 Tucson📍 New York📍 New York California Pacific Medical Center Research Institute · Tests: Positive airway pressure, Oral appliance therapy, Positional therapy Understanding Brain Mechanisms Involved in Autobiographical Memory NCT05710549NA1 site📍 Geneva Lucie Bréchet · Tests: high-density electroencephalography (hdEEG), Transcranial alternating current stimulation (tACS) Genetics in Parkinson's Disease: Behavioral and Cognitive Outcomes NCT06329739n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Clinical examinations and clinical scales administration Whole-Body Photobiomodulation for Motor and Cognitive Changes in Parkinson's Disease NCT07271927NA1 site📍 Yangsan Pusan National University Yangsan Hospital · Tests: Photobiomodulation The Effect of Urolithin A (Mitopure®) on Alzheimer's Disease NCT07842146NA1 site📍 Prague University Hospital, Akershus · Tests: Urolithin A, Placebo Control
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy